Financials in USD. Standardized financial statements.
A compact view of how U.S. NeuroSurgical Holdings, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $1.02M | $0 | $0 | $0 | $1.06M | $3.17M | $3.07M | $3.42M | $3.41M | $3.21M |
| Revenue Growth? | 0.0% | 0.0% | 0.0% | -100.0% | -66.6% | +3.4% | -10.3% | +0.3% | +6.3% | 0.0% |
| Cost of Revenue? | $906,000 | $13,000 | $20,000 | $39,000 | $86,000 | $361,000 | $350,000 | $1.34M | $1.47M | $1.29M |
| Gross Profit? | $118,000 | -$13,000 | -$20,000 | -$39,000 | $975,000 | $2.81M | $2.72M | $2.08M | $1.95M | $1.92M |
| Gross Margin? | +11.5% | 0.0% | 0.0% | 0.0% | +91.9% | +88.6% | +88.6% | +60.8% | +57.0% | +59.8% |
| Operating Expenses? | $3.96M | $1.78M | $745,000 | $1.35M | $1.06M | $1.20M | $1.23M | $1.29M | $1.26M | $1.31M |
| Operating Income? | -$3.84M | -$1.79M | -$765,000 | -$1.39M | -$88,000 | $1.61M | $242,000 | $131,000 | $688,000 | $614,000 |
| EBITDA? | -$3.84M | -$2.21M | -$49,000 | -$1.49M | -$515,000 | $915,000 | $275,000 | $131,000 | $1.85M | $2.07M |
| Income Before Tax | -$7.80M | -$2.22M | -$816,000 | -$1.53M | -$554,000 | $856,000 | $151,000 | -$613,000 | $441,000 | $878,000 |
| Income Tax Expense | $0 | -$163,000 | $0 | $39,000 | $420,000 | $323,000 | $9,000 | -$192,000 | -$97,000 | $342,000 |
| Net Income? | -$7.80M | -$2.06M | -$816,000 | -$1.57M | -$881,000 | $533,000 | $142,000 | -$421,000 | $538,000 | $536,000 |
| EPS? | $-0.35 | $-0.13 | $-0.09 | $-0.17 | $-0.11 | $0.07 | $0.02 | $-0.05 | $0.07 | $0.07 |
| Diluted EPS? | $-0.35 | $-0.13 | $-0.09 | $-0.17 | $-0.11 | $0.07 | $0.02 | $-0.05 | $0.07 | $0.07 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality